InfuSystem (INFU) Competitors $5.41 -0.39 (-6.72%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$5.44 +0.03 (+0.55%) As of 05/23/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock INFU vs. SMLR, TMCI, CLPT, NNOX, STIM, SMTI, SNWV, ZIMV, TCMD, and NYXHShould you be buying InfuSystem stock or one of its competitors? The main competitors of InfuSystem include Semler Scientific (SMLR), Treace Medical Concepts (TMCI), ClearPoint Neuro (CLPT), Nano-X Imaging (NNOX), Neuronetics (STIM), Sanara MedTech (SMTI), SANUWAVE Health (SNWV), ZimVie (ZIMV), Tactile Systems Technology (TCMD), and Nyxoah (NYXH). These companies are all part of the "medical equipment" industry. InfuSystem vs. Semler Scientific Treace Medical Concepts ClearPoint Neuro Nano-X Imaging Neuronetics Sanara MedTech SANUWAVE Health ZimVie Tactile Systems Technology Nyxoah InfuSystem (NYSE:INFU) and Semler Scientific (NASDAQ:SMLR) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, dividends, institutional ownership, profitability, valuation and community ranking. Do analysts rate INFU or SMLR? InfuSystem presently has a consensus price target of $13.00, suggesting a potential upside of 140.30%. Semler Scientific has a consensus price target of $71.00, suggesting a potential upside of 60.20%. Given InfuSystem's stronger consensus rating and higher possible upside, analysts plainly believe InfuSystem is more favorable than Semler Scientific.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score InfuSystem 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 2 Strong Buy rating(s) 4.00Semler Scientific 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders & institutionals have more ownership in INFU or SMLR? 71.1% of InfuSystem shares are owned by institutional investors. Comparatively, 49.4% of Semler Scientific shares are owned by institutional investors. 11.4% of InfuSystem shares are owned by insiders. Comparatively, 30.2% of Semler Scientific shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has better earnings and valuation, INFU or SMLR? Semler Scientific has lower revenue, but higher earnings than InfuSystem. Semler Scientific is trading at a lower price-to-earnings ratio than InfuSystem, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInfuSystem$137.58M0.83$870K$0.1438.64Semler Scientific$49.23M10.04$20.58M-$2.61-16.98 Does the media favor INFU or SMLR? In the previous week, Semler Scientific had 9 more articles in the media than InfuSystem. MarketBeat recorded 13 mentions for Semler Scientific and 4 mentions for InfuSystem. InfuSystem's average media sentiment score of 1.22 beat Semler Scientific's score of 0.67 indicating that InfuSystem is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InfuSystem 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Semler Scientific 5 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk & volatility, INFU or SMLR? InfuSystem has a beta of 1.73, indicating that its share price is 73% more volatile than the S&P 500. Comparatively, Semler Scientific has a beta of 1.33, indicating that its share price is 33% more volatile than the S&P 500. Is INFU or SMLR more profitable? Semler Scientific has a net margin of 72.65% compared to InfuSystem's net margin of 1.12%. Semler Scientific's return on equity of 50.77% beat InfuSystem's return on equity.Company Net Margins Return on Equity Return on Assets InfuSystem1.12% 2.78% 1.41% Semler Scientific 72.65%50.77%47.04% Does the MarketBeat Community favor INFU or SMLR? InfuSystem received 9 more outperform votes than Semler Scientific when rated by MarketBeat users. Likewise, 100.00% of users gave InfuSystem an outperform vote while only 50.00% of users gave Semler Scientific an outperform vote. CompanyUnderperformOutperformInfuSystemOutperform Votes11100.00% Underperform VotesNo VotesSemler ScientificOutperform Votes250.00% Underperform Votes250.00% SummaryInfuSystem beats Semler Scientific on 11 of the 19 factors compared between the two stocks. Get InfuSystem News Delivered to You Automatically Sign up to receive the latest news and ratings for INFU and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INFU vs. The Competition Export to ExcelMetricInfuSystemSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$113.70M$4.44B$5.34B$19.26BDividend YieldN/A45.13%5.27%3.86%P/E Ratio90.1829.9426.9634.42Price / Sales0.8369.02398.8334.89Price / Cash12.7951.0838.3217.51Price / Book2.196.186.774.69Net Income$870,000.00$68.15M$3.24B$1.02B7 Day Performance-12.03%-1.95%0.27%-2.38%1 Month Performance8.85%11.54%5.91%4.18%1 Year PerformanceN/A20.30%18.83%4.87% InfuSystem Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INFUInfuSystem2.4237 of 5 stars$5.41-6.7%$13.00+140.3%N/A$113.70M$137.58M90.18410SMLRSemler Scientific2.6807 of 5 stars$43.27+5.8%$71.00+64.1%+90.1%$482.55M$56.29M8.81120Trending NewsAnalyst DowngradeOptions VolumeGap DownHigh Trading VolumeTMCITreace Medical Concepts2.2607 of 5 stars$6.73+0.1%$10.16+50.9%+14.0%$423.25M$210.82M-6.80250Trending NewsCLPTClearPoint Neuro1.6636 of 5 stars$13.12-0.5%$25.00+90.5%+102.6%$368.90M$31.39M-19.01110Analyst DowngradeGap DownNNOXNano-X Imaging1.3708 of 5 stars$5.48-2.1%$12.00+119.0%-39.1%$316.63M$11.28M-6.45190Trending NewsEarnings ReportAnalyst ForecastSTIMNeuronetics1.4166 of 5 stars$4.29+1.7%$5.50+28.2%+83.0%$282.37M$89.45M-3.49180SMTISanara MedTech1.7645 of 5 stars$31.18-1.0%$49.50+58.8%-2.0%$277.13M$86.67M-31.4960SNWVSANUWAVE HealthN/A$29.58-8.4%N/AN/A$253.09M$36.19M-6.4940News CoverageAnalyst DowngradeZIMVZimVie2.2685 of 5 stars$8.75-2.9%$16.33+86.7%-50.7%$243.66M$443.55M-0.672,700Positive NewsTCMDTactile Systems Technology3.5853 of 5 stars$10.40flat$16.00+53.8%-26.7%$241.78M$293.16M14.86980Positive NewsNYXHNyxoah2.9203 of 5 stars$6.79+7.9%$14.50+113.5%-8.9%$231.27M$4.52M-3.63110Gap UpHigh Trading Volume Related Companies and Tools Related Companies SMLR Competitors TMCI Competitors CLPT Competitors NNOX Competitors STIM Competitors SMTI Competitors SNWV Competitors ZIMV Competitors TCMD Competitors NYXH Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:INFU) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InfuSystem Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share InfuSystem With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy INFU Stock Free INFU Stock Alerts